miR-222 inhibits pathological cardiac hypertrophy and heart failure.
Liu X, Li H, Hastings MH, Xiao C, Damilano F, Platt C, Lerchenmüller C, Zhu H, Wei XP, Yeri A, Most P, Rosenzweig A.
Liu X, et al. Among authors: zhu h.
Cardiovasc Res. 2024 Mar 14;120(3):262-272. doi: 10.1093/cvr/cvad184.
Cardiovasc Res. 2024.
PMID: 38084908